ARDX CIK: 1437402

Ardelyx Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
134
FY22:
154
FY23:
246
FY24:
356
FY25:
382
(positive)
Change from FY21 to FY25
millions USD
FY21:
16.3
FY22:
36.5
FY23:
51.5
FY24:
79.3
FY25:
119
Total assets
Change from FY21 to FY25
millions USD
FY21:
150
FY22:
190
FY23:
298
FY24:
436
FY25:
502

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
52.8
FY22:
65.6
FY23:
50.4
FY24:
77.8
FY25:
88.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.5
FY22:
26.1
FY23:
80.4
FY24:
185
FY25:
246
(positive)
Change from FY21 to FY25
millions USD
FY21:
82.6
FY22:
98.3
FY23:
167
FY24:
173
FY25:
167
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
150
FY22:
190
FY23:
298
FY24:
436
FY25:
502

All amounts in millions USD Data sources:SEC EDGARTwelve Data